Skip to main content

GBT2104-131 A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease (SCD) Experiencing Vaso-occlusive Crisis (VOCs)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Hematology

Awarded By

Global Blood Therapeutics, Inc.

Start Date

June 4, 2021

End Date

May 31, 2024
 

Administered By

Medicine, Hematology

Awarded By

Global Blood Therapeutics, Inc.

Start Date

June 4, 2021

End Date

May 31, 2024